Early ribavirin treatment and avoidance of corticosteroids in hepatitis C virus (HCV)-positive liver transplant recipients: interim report of a prospective randomized trial.
Belli
L S
LS
Divisione Medica "Crespi", Milano, Italy. isbelli@tin.it
Alberti
A B
AB
Rondinara
G F
GF
de Carlis
L
L
Corti
A
A
Mazza
E
E
Airoldi
A
A
Cernuschi
A
A
de Gasperi
A
A
Forti
D
D
Pinzello
G B
GB
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005500:Follow-Up Studies; D006526:Hepatitis C / Q000201:enzymology / Q000517:prevention & control*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008099:Liver / Q000201:enzymology; D016031:Liver Transplantation / Q000276:immunology*; D011183:Postoperative Complications / Q000517:prevention & control; D011446:Prospective Studies; D012254:Ribavirin / Q000627:therapeutic use*; D055502:Secondary Prevention
D000305:Adrenal Cortex Hormones; D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons